We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Heart Disease May Be Worsened by Aggressive T Cells
News

Heart Disease May Be Worsened by Aggressive T Cells

Heart Disease May Be Worsened by Aggressive T Cells
News

Heart Disease May Be Worsened by Aggressive T Cells

T cells may drive inflammation as dangerous plaques build up in the cardiovascular system. Credit: La Jolla Institute for Immunology
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Heart Disease May Be Worsened by Aggressive T Cells"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries.


The challenge is that the T cells involved in atherosclerosis are very rare and extremely hard to find in the bloodstream. "This is a classic needle-in-the-haystack problem," says La Jolla Institute for Immunology (LJI) Professor Klaus Ley, M.D.


But T cells can't hide forever. In a study published recently in Nature Cardiovascular Research, Ley and his colleagues describe a group of T cells that attack a protein called apolipoprotein B (APOB).


APOB is the main protein component of LDL, or "bad," cholesterol. Dangerous plaques can form in the arteries as LDL levels increase in the bloodstream. These plaques can drive inflammation, block blood flow, and even break apart to trigger strokes and heart attacks.


Ley and his colleagues discovered that T cells that target APOB may contribute to inflammation and further the progression of atherosclerosis. In fact, follow-up experiments in mice showed that as the disease gets worse, a phenomenon called T cell "expansion" leads to more and more of these APOB-reactive T cells in the bloodstream.


"The APOB-specific T cells become more aggressive once the disease has started," says Ley.


The new study is the first to describe the T cells involved in atherosclerosis with a high level of detail. Ley and his colleagues analyzed blood samples from eight women in a diverse cohort of women in their 50s and 60s (volunteers in the NIH-funded Women’s Interagency HIV Study).


The LJI team collaborated with scientists at Albert Einstein College of Medicine to carefully analyze more than 12,000 T cells from these patients using two cutting edge techniques: single-cell RNA sequencing and T cell receptor sequencing. In this huge pool of T cells, 110 cells stood out, and the scientists found these cells were capable of targeting APOB.


As they zoomed in further, the researchers found that the T cells targeting APOB resemble a type of T cell called a regulatory T cell (Treg), which normally regulates inflammation. Yet these T cells weren't behaving like normal Tregs. It appears that these new T cells develop a new identity as heart disease develops.


This study is good news for the future of treating heart disease. Ley says detecting these T cells may lead to diagnostics to better detect heart disease—and disease severity—through a blood sample. The knowledge also brings Ley closer to developing a vaccine that dampens this dangerous immune cell activity to prevent atherosclerosis.


Going forward, Ley plans to look at a wider patient group that also includes men with atherosclerosis. He hopes to connect with more patients with cardiovascular disease and work with their doctors to collect small blood samples for clinical research. "The limiting factor in this work is access to patient samples," he says.


Reference: Saigusa R, Roy P, Freuchet A, et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat Cardiovasc Res. 2022;1(5):462-475. doi: 10.1038/s44161-022-00063-3

  

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement